Fatemeh Khosravi Shadmani

ORCID: 0000-0002-5172-7950
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Colorectal Cancer Screening and Detection
  • Global Cancer Incidence and Screening
  • SARS-CoV-2 and COVID-19 Research
  • Global Public Health Policies and Epidemiology
  • Statistical Methods in Epidemiology
  • COVID-19 Clinical Research Studies
  • COVID-19 epidemiological studies
  • Obesity, Physical Activity, Diet
  • Nutritional Studies and Diet
  • Injury Epidemiology and Prevention
  • Nutrition and Health in Aging
  • COVID-19 and Mental Health
  • Traffic and Road Safety
  • Healthcare Systems and Reforms
  • Health Promotion and Cardiovascular Prevention
  • Long-Term Effects of COVID-19
  • Vaccine Coverage and Hesitancy
  • Economic and Financial Impacts of Cancer
  • Global Health Care Issues
  • HIV, Drug Use, Sexual Risk
  • Child Nutrition and Water Access
  • Trauma and Emergency Care Studies
  • Liver Disease Diagnosis and Treatment
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Multiple and Secondary Primary Cancers

Kermanshah University of Medical Sciences
2015-2025

Zanjan University of Medical Sciences
2020-2024

Tabriz University of Medical Sciences
2023

Sulaimani Polytechnic University
2023

Kerman University of Medical Sciences
2016-2020

Dezful University of Medical Sciences
2020

Tehran University of Medical Sciences
2020

Shahid Beheshti University of Medical Sciences
2013-2019

Akram Pourshams Sadaf G Sepanlou Kevin S Ikuta Catherine Bisignano Saeid Safiri and 95 more Gholamreza Roshandel Mehdi Sharif Morteza Khatibian Christina Fitzmaurice Molly R Nixon Nooshin Abbasi Mohsen Afarideh Elham Ahmadian Tomi Akinyemiju Fares Alahdab Shazia Alam Vahid Alipour Christine A. Allen Nahla Anber Alireza Ansari-Moghaddam Jalal Arabloo Alaa Badawi Mojtaba Bagherzadeh Yaschilal Muche Belayneh Belete Biadgo Ali Bijani Antonio Biondi Tone Bjørge Antonio Maria Borzì Cristina Bosetti Andrey Briko Н. И. Брико Giulia Carreras Félix Carvalho Jee-Young Jasmine Choi Dinh‐Toi Chu Anh Kim Dang Ahmad Daryani Dragoş Virgil Daviţoiu Gebre Teklemariam Demoz Rupak Desai Subhojit Dey Hoa Do Huyen Phuc Aziz Eftekhari Alireza Esteghamati Farshad Farzadfar Eduarda Fernandes Irina Filip Florian Fischer Masoud Foroutan Mohamed M. Gad Silvano Gallus Birhanu Geta Giuseppe Gorini Nima Hafezi‐Nejad James Harvey Milad Hasankhani Amir Hasanzadeh Soheil Hassanipour Simon I Hay Hagos D Hidru Chi Linh Hoang Sorin Hostiuc Mowafa Househ Olayinka Stephen Ilesanmi Milena Ilić Seyed Sina Naghibi Irvani Nader Jafari Balalami Spencer L James Farahnaz Joukar Amir Kasaeian Tesfaye Kassa André Pascal Kengne Rovshan Khalilov Ejaz Ahmad Khan Amir M Khater Fatemeh Khosravi Shadmani Jonathan Kocarnik Hamidreza Komaki Ai Koyanagi Vivek Kumar Carlo La Vecchia Platon D Lopukhov Farzad Manafi Navid Manafi Ana-Laura Manda Fariborz Mansour‐Ghanaei Dhruv Mehta Varshil Mehta Toni Meier Hagazi Gebre Meles Getnet Mengistu Tomasz Miazgowski Mehdi Mohamadnejad Abdollah Mohammadian-Hafshejani Milad Mohammadoo-Khorasani Shafiu Mohammed Farnam Mohebi Ali H. Mokdad

Worldwide, both the incidence and death rates of pancreatic cancer are increasing. Evaluation burden its global, regional, national patterns is crucial to policy making better resource allocation for controlling risk factors, developing early detection methods, providing faster more effective treatments.Vital registration, vital registration sample, registry data were used generate mortality, incidence, disability-adjusted life-years (DALYs) estimates. We comparative assessment framework...

10.1016/s2468-1253(19)30347-4 article EN cc-by ˜The œLancet. Gastroenterology & hepatology 2019-10-21

Since the first official report of SARS-CoV-2 infection in Iran on 19 February 2020, our country has been one worst affected countries by COVID-19 epidemic Middle East. In addition to demographic and clinical characteristics, number hospitalized cases deaths is an important factor for evidence-based decision-making disease control preparing healthcare system face future challenges COVID-19. Therefore, this cohort study was conducted determine demographics, outcomes patients Kermanshah...

10.1186/s12879-022-07312-7 article EN cc-by BMC Infectious Diseases 2022-03-31

Background Alcohol consumption has become very common among adolescents in recent years and its prevalence varies different countries. This study aimed to investigate the of alcohol related factors aged 11 16 years. Methods descriptive cross-sectional was performed on 288385 (girls, 53.9% total) In present study, GSHS data (2003–2018) available public websites US Centers for Disease Control Prevention (CDC) WHO used. To affecting consumption, univariate multivariate logistics models with 95%...

10.1371/journal.pone.0297225 article EN cc-by PLoS ONE 2024-04-01

Abstract Background Interactions between risk factors may influence disease severity. Knowing this relationship is important for preventive interventions and control. The purpose of study was to determine the interactions effects obesity hypertension on type 2 diabetes mellitus (T2DM). Methods data 9,283 adults 35 65 years were examined from cohort Ravansar Non-Communicable Disease (RaNCD). Waist circumference (WC) used identify both general abdominal based body mass index (BMI). To assess...

10.1186/s12889-024-18290-7 article EN cc-by BMC Public Health 2024-03-11

Colorectal cancer (CRC) is the third most common and fourth cause of death in world. The aim this study was to investigate provincial distribution incidence CRC across Iran.This epidemiologic used data from National Cancer Registry Iran Center for Disease Control Prevention Ministry Health Medical Education Iran. average annual age-standardized rate (ASR) calculated each province.We found that adenocarcinoma (not otherwise specified) histological subtype males females, accounting 81.91...

10.4178/epih.e2017020 article EN cc-by Epidemiology and Health 2017-05-17

Background Following the epidemiologic and demographic transition, non-communicable disease mortality is leading cause of death in Iran. Projecting trend can provide valuable tools for policy makers planners. In this article, we have estimated during 2001–2015 projected it until 2030 at national subnational levels Methods The data employed was gathered from Iranian registration system using Spatio-temporal model, trends 4 major categories diseases (cancers, cardiovascular diseases, asthma...

10.1371/journal.pone.0211622 article EN cc-by PLoS ONE 2019-02-14

Background and Objectives: During the COVID-19 pandemic, vaccination was crucial in preventing spread of SARS-CoV-2 saving numerous lives. Countries implementing programs have reported significant reductions cases, ICU admissions, COVID-19-related deaths. This study aimed to evaluate effectiveness vaccines used Hamadan province, explicitly focusing on their impact hospitalization death caused by COVID-19. Methods: A test-negative case-control design (TND) conducted involving patients aged 12...

10.18502/ijre.v20i1.17625 article EN cc-by-nc Majallah-i ipīdimīyuluzhī-i Īrān/Majallah-i ipīdimīyuluzhī-i Īrān 2025-01-15

Background Breast cancer (BC) is the second most common in world. This study aimed to investigate burden of BC due some risk factors Middle East and North Africa (MENA) countries from 1990 2019. Methods a secondary analysis based on Global Burden Disease 2019 data. In this study, we used data for disability-adjusted life years (DALYs) mortality MENA countries. Also, presented DALYs attributed diabetes, smoking passive among women with BC. Results The age-standardised DALY increased slowly...

10.1136/bmjopen-2024-087178 article EN cc-by-nc-nd BMJ Open 2025-01-01

Given the limited evidence on side effects of AZD1222 booster in individuals previously vaccinated with Sinopharm BBIBP-CorV, we conducted a cohort event monitoring study to capture adverse events those receiving doses (first or second) after BBIBP-CorV vaccination Iran. This active COVID-19 vaccine safety surveillance was centers across 12 provinces The population included who had received two and either first second dose. Each participant followed for 13 weeks their A total 28,742...

10.1186/s12889-025-21805-5 article EN cc-by-nc-nd BMC Public Health 2025-02-17

Background Cancer is a rapidly increasing global problem, and one of the leading causes burden mortality. This study aims to compare cancer in Iran between year 1990 2019. Methods We used Global Burden Disease data on from 2019 by province, year, age group, sex. then estimated trend standardized mortality Disability-Adjusted Life Years (DALYs) cancers Age pattern geographical variation ranking were assessed at national sub-national levels Results The rate decreased 102 (95% UI: 91, 111) 96...

10.1371/journal.pone.0309699 article EN cc-by PLoS ONE 2025-02-25

Abstract This study aims to investigate the trends and project major risk factors of Non-communicable Diseases (NCDs) in Iran. We obtained trend prevalence main related NCDs 30 70-year-old-individuals. The data were extracted from WHO STEP wise approach factor surveillance (STEPS) survey. Also,the previous studies conducted at national subnational levels 2001 2016 employed. was projected by 2030 using Bayesian Model Averaging (BMA) Spatio-temporal model stratified sex province. percent...

10.1038/s41598-024-58629-z article EN cc-by Scientific Reports 2024-04-06

Abstract Aim and background Smoking is a modifiable risk factor for cancers. The aim of the study to estimate trend mortality DALYs smoking-attributed cancers in North Africa Middle East (NAME) countries. Methods In this study, estimates from Global Burden Disease 2019 (GBD-2019) were used report 16 rates evaluated by age, sex, 21 countries NAME 1990 2019. Results Age standardized (ASMR) 29 estimated be 24.7 (95% Uncertainty Interval: 21.5, 27.8) 22.4 (95%UI: 19.8, 25.4) respectively, which...

10.1186/s12885-023-10563-5 article EN cc-by BMC Cancer 2023-01-24

Abstract Objectives Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the COVID-19 pandemic. The majority of patients experience asymptomatic to mild self-limited disease, but some cases progress and multi-organ failure. However, so far, no approved antiviral therapy has been available treatment COVID-19. Sofosbuvir/velpatasvir (SOF/VEL) an anti-HCV drug that capable suppressing other families positive-sense RNA viruses with conserved polymerase may be effective...

10.1093/jac/dkab152 article EN other-oa Journal of Antimicrobial Chemotherapy 2021-05-14

Introduction: Brucellosis is a common global zoonotic disease with wide range of complex and nonspecific clinical manifestations that may lead to misdiagnosis delayed treatment. Osteoarticular involvement the most complaint in brucellosis. Objective: This present study aims describe laboratory characteristics treatment brucellosis patients arthritis sacroiliitis. Methods: retrospective descriptive was performed on presenting teaching hospital Kermanshah, Iran diagnosis from 2011 2019. The...

10.1177/20499361241246937 article EN cc-by-nc Therapeutic Advances in Infectious Disease 2024-01-01

Cardiovascular diseases (CVD) stand out as the leading cause of mortality, and mortality rate attributed to this disease is notably elevated in Iran. Consequently, dedicated studies on CVD become imperative.

10.1016/j.cpcardiol.2024.102675 article EN cc-by Current Problems in Cardiology 2024-05-23

Abstract Insufficient physical activity (IPA) caused approximately 5% of mortalities in 2017 Iran, almost double its global average. Despite the relatively considerable burden, a knowledge gap exists regarding trend IPA recent years. We described prevalence utilizing data from six rounds STEPwise approach to risk factor Surveillance (STEPS) Iran. estimated status Iranian adults 2006 2016 after adjusting for years schooling, urbanization percentage, and wealth index. used spatiotemporal model...

10.1038/s41598-021-00252-3 article EN cc-by Scientific Reports 2021-11-02

High BMI related burden of knee and hip osteoarthritis (OA) is on a significant rise worldwide. OA not only causes joint pain stiffness, but it also leads to disability. This study investigated the trend attributable high body mass index (BMI) in Iran. The age-standardized disability-adjusted life years (DALYs) rates due BMI, were estimated using data from Global Burden Disease 2019. We evaluated DALYs rate by sex age span 30 1990-2019 across 31 provinces prevalence showed an increase 1990...

10.1038/s41598-023-37780-z article EN cc-by Scientific Reports 2023-07-20

Vaccine effectiveness (VE) studies provide real-world evidence to monitor vaccine performance and inform policy. The WHO Regional Office for the Eastern Mediterranean supported a regional study assess VE of COVID-19 vaccines against different clinical outcomes in four countries between June 2021 August 2023. Health worker cohort were conducted 2707 health workers Egypt Pakistan, whom 171 experienced symptomatic laboratory-confirmed SARS-CoV-2 infection. Test-negative design case–control Iran...

10.3390/vaccines12080906 article EN cc-by Vaccines 2024-08-10

Introduction This study measures the COVID-19 vaccine effectiveness (CVE) against hospital admission and severe COVID-19. Methods is a test-negative case-control design using data from eight provinces in April, 2021 until March, 2022. The individuals were classified as cases controls based on results of RT-PCR test for SARS-CoV-2 matched timing being conducted well admission. measure association was an odds ratio (OR) by univariate multiple logistic regression. regression has been carried...

10.3389/fimmu.2024.1420651 article EN cc-by Frontiers in Immunology 2024-08-20

Background: A geographic disparity for breast cancer (BC) incidence by provinces is introduced in Iran. Present study aimed to clarify the of BC after considering age and gender.
 Methods: In this ecological data about extracted from reports national registry (NCR), Disease Control Prevention 2008. mapping was conducted information system (GIS).
 Results: The results were consistent with previous but extend knowledge regarding gender. Highest specific rates (ASRs) occurred located...

10.15419/bmrat.v4i05.168 article EN Biomedical Research and Therapy 2017-05-21
Coming Soon ...